Biomedical Engineering Reference
In-Depth Information
36. Franzoso G., Carlson L., Xing L. P., Poljak L., Shores E. W., Brown K. D., Leonardi
A., Tran T., Boyce B. F., Siebenlist U. Requirement for NF-kappa B in osteoclast
and B-cell development.
Genes & Development
11 (24): 3482-3496 (1997).
37. Matsuo K., Galson D. L., Zhao C., Peng L., Laplace C., Wang K. Z. Q.,
Bachler M. A., et al. Nuclear factor of activated T-cells (NFAT) rescues
osteoclastogenesis in precursors lacking c-Fos.
Journal of Biological Chemistry
279 (25): 26475-26480 (2004).
38. Hsu H., Lacey D. L., Dunstan C. R., Solovyev I., Colombero A., Timms E.,
Tan H-L., et al. Tumor necrosis factor receptor family member RANK mediates
osteoclast differentiation and activation induced by osteoprotegerin ligand.
Proceedings of the National Academy of Sciences
96 (7): 3540-3545 (1999).
39. Aubin J. E. Bone stem cells.
Journal of Cellular Biochemistry Supplement
30-31: 73-82 (1998).
40. Jilka R. L., Weinstein R. S., Bellido T., Parfitt A. M., Manolagas S. C. Osteoblast
programmed cell death (apoptosis): Modulation by growth factors and
cytokines.
Journal of Bone Mineral Research
13 (5): 793-802 (1998).
41. Knauer D. J., Wiley H. S., Cunningham D. D. Relationship between epidermal
growth factor receptor occupancy and mitogenic response. Quantitative
analysis using a steady state model system.
Journal of Biological Chemistry
259 (9): 5623-5631 (1984).
42. Lauffenburger D. A., Linderman J. J.
Receptors. Models for binding, trafficking, and
signaling.
New York: Oxford University Press (1996).
